To come up with a monoclonal antibody to fight cancer, Tepper's group uses a strain of mice whose immune systems are genetically engineered to .
The monoclonal antibodies used against cancer are proteins designed to latch on to a specific molecule on the surface of a tumor cell, while leaving normal cells untouched.
Public company based in Melbourn, England CEO: Peter Chambr What it does: Develops human monoclonal antibodies as treatment for disease.
Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of ... Bristol-Myers Squibb Company and AbbVie today announced updated efficacy and safety data from a small, randomized Phase 2, open-label study in patients with previously-treated multiple myeloma that evaluated two doses of the investigational monoclonal antibody elotuzumab in combination with lenalidomide and low-dose dexamethasone.
June 15, 2013 - Business Wire via Yahoo! Finance
Immunomedics to Present at Wells Fargo Securities 2013 Healthcare Conference MORRIS PLAINS, N.J. -- Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other ...
June 14, 2013 - GlobeNewswire via Yahoo! Finance
Kiran Mazumdar-Shaw in Zee News Mazumdar-Shaw, however, added that "the new growth drivers -- insulin, immuno-suppressants, branded formulations and monoclonal antibodies are building the bio-pharmaceuticals business in a more robust manner and reducing the dependence on statins".
Toru Iwatani in PR Newswire (press release) The Biolex team has successfully produced a wide range of human proteins and monoclonal antibodies including Plasminogen, a protein that contains multiple kringle domains similar to those in NK4,said Mr. Kunio Iwatani, Chief Executive Officer...
Thomas Caskey in HealthNewsDigest.com The use of immunological therapy involving monoclonal antibodies has revolutionized the treatment of many important diseases,said C. Thomas Caskey, MD, director/CEO of the IMM. "The bold new approach to Parkinson's disease by Drs. Chang...